37 results on '"Bortoluzzi I"'
Search Results
2. The role of hepatitis C virus eradication with DAA on insulin resistence regulation
3. Insulin resistance improvement after effective Hepatitis C virus eradication and its role on the onset of complications of advanced liver disease
4. P.06.18: Role of Sharkscore Needle Biopsy in EUS-Endoscopy: Is a Single Pass Enough?
5. OC.13.1: Eradication of HCV in Patients Awaiting Liver Transplantation does not Increase Drop-Out Due to HCC Progression
6. Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression
7. Characterisation of the immune response in patients with drug induced liver injury
8. Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy
9. Characterisation of the immune response in patients with drug induced liver injury
10. Decreased hypercoagulable state in hepatitis C virus-cirrhotic patients treated with DAA: the outcome revolution
11. Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation
12. HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience
13. OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT)
14. Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy
15. Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
16. OC.03.7 CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
17. P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
18. Presentation and outcome in patients with drug induced liver injury: A three-year experience
19. Transition of pediatric liver transplanted recipients to Adult Healthcare Service: A single center cohort
20. Transition of Pediatric Liver Transplanted Recipients to Adult Healthcare Service: A Single Center Cohort
21. Circulating Microparticles and Risk of Portal Vein Thrombosis in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
22. Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test
23. P0074 : Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience
24. PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
25. P931 EFFECTS OF NON-SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)
26. P930 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS
27. P.16.10 EFFECTS OF NON SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP)
28. OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS
29. Italian survey on HBV and liver transplantation in a cohort of 2260 patients
30. Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis
31. Use of Grafts From Anti-HBc–Positive Donors in Liver Transplantation: A 5-Year, Single-Center Experience
32. 235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS
33. 141 USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE
34. F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center
35. F-33 Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients
36. P1111 EFFECTIVENESS OF WEEKLY ORAL IRON SUPPLEMENTATION IN INCREASING HEMOGLOBIN LEVEL IN TERENA INDIAN CHILDREN FROM MATO GROSSO DO SUL, BRAZIL
37. P1111 EFFECTIVENESS OF WEEKLY ORAL IRON SUPPLEMENTATION IN INCREASING HEMOGLOBIN LEVEL IN TERENA INDIAN CHILDREN FROM MATO GROSSO DO SUL, BRAZIL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.